These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
318 related articles for article (PubMed ID: 30989996)
21. [Evaluation and analysis of high-quality products of Liuwei Dihuang Pills]. Liu Y; Zhao AY; Ni FY; Yu HC; Cheng JT; DI JP; Liu YZ; Wang ZG; Liu A Zhongguo Zhong Yao Za Zhi; 2020 Mar; 45(5):1194-1201. PubMed ID: 32237465 [TBL] [Abstract][Full Text] [Related]
22. [Innovation of traditional Chinese medicine compounds and patent layout strategy with Lianhua Qingwen Formula as example]. Li WH; Li YH; Shan XG Zhongguo Zhong Yao Za Zhi; 2021 Mar; 46(5):1293-1300. PubMed ID: 33787125 [TBL] [Abstract][Full Text] [Related]
23. [Strategy of constructing post-market integral evaluation system of traditional Chinese medicine injection]. Zhang XY; Wang YP; Lin LK; Shang HC; Wang YY Zhongguo Zhong Yao Za Zhi; 2017 Aug; 42(16):3229-3232. PubMed ID: 29171246 [TBL] [Abstract][Full Text] [Related]
24. [Development of whole process quality control and management system of traditional Chinese medicine decoction pieces based on traditional Chinese medicine quality tree]. Yu WK; Dong L; Pei WX; Sun ZR; Dai JD; Wang Y Zhongguo Zhong Yao Za Zhi; 2017 Dec; 42(23):4488-4493. PubMed ID: 29376242 [TBL] [Abstract][Full Text] [Related]
25. [Cluster analysis on authorized patents of compound traditional Chinese medicines with different efficacy in 2010]. Yang X; Xiao S; Guo Z Zhongguo Zhong Yao Za Zhi; 2012 Aug; 37(16):2478-82. PubMed ID: 23234154 [TBL] [Abstract][Full Text] [Related]
26. [Construction of theoretical model of traditional Chinese medicine intelligent manufacturing]. Cao TT; Wang Y Zhongguo Zhong Yao Za Zhi; 2019 Jul; 44(14):3123-3127. PubMed ID: 31602862 [TBL] [Abstract][Full Text] [Related]
27. The Correlation between Enterprise Internal Control Quality and Research and Development Investment Intensity. Hu S; Yang H Comput Intell Neurosci; 2022; 2022():1788142. PubMed ID: 35785049 [TBL] [Abstract][Full Text] [Related]
28. Does the Low-Carbon City Pilot Policy Promote Green Technology Innovation? Based on Green Patent Data of Chinese A-Share Listed Companies. Ma J; Hu Q; Shen W; Wei X Int J Environ Res Public Health; 2021 Apr; 18(7):. PubMed ID: 33916230 [TBL] [Abstract][Full Text] [Related]
29. [Thoughts on post-marketing evaluation of classical Chinese patent medicines based on clinical value]. Song Z; Wang ZF; Wu Y; Xie YM; Yang YF; Xu Y Zhongguo Zhong Yao Za Zhi; 2021 Apr; 46(8):1988-1993. PubMed ID: 33982509 [TBL] [Abstract][Full Text] [Related]
30. [Patent application of intelligent quality control technology in traditional Chinese medicine production process: a review]. Tang XF; Qi FY; Wang TJ; Liang ZC; Qiao YJ; Xiao W; Xu B Zhongguo Zhong Yao Za Zhi; 2023 Jun; 48(12):3190-3198. PubMed ID: 37382002 [TBL] [Abstract][Full Text] [Related]
31. [Expert consensus on prescription comment of Chinese traditional patent medicine for promoting the rational use of drugs in Beijing]. Jin R; Zhao KJ; Guo GM; Zhang B; Wang YG; Xue CM; Yang YH; Wang LX; Li GH; Tang JF; Nie LX; Zhang XL; Zhao TT; Zhang Y; Yan C; Yuan SZ; Sun LL; Feng XZ; Yan D; Zhongguo Zhong Yao Za Zhi; 2018 Mar; 43(5):1049-1053. PubMed ID: 29676107 [TBL] [Abstract][Full Text] [Related]
32. [Discovery, research and development for innovative drug of traditional Chinese medicine under new situations]. Tu PF; Jiang Y; Guo XY Zhongguo Zhong Yao Za Zhi; 2015 Sep; 40(17):3423-8. PubMed ID: 26978984 [TBL] [Abstract][Full Text] [Related]
33. [Development strategy of Paris based on combination of domestic patent and current resource application and development]. Zhao FY; Tao AE; Xia CL Zhongguo Zhong Yao Za Zhi; 2018 Jan; 43(2):404-409. PubMed ID: 29552863 [TBL] [Abstract][Full Text] [Related]
34. [Retrospective analysis and discussion on 74 cases of adverse reactions of traditional Chinese medicine injection]. Wang Y; Fan LP; Song J; Cai YP; Jinang TT; Wang YG; Kong XW; Wu JR Zhongguo Zhong Yao Za Zhi; 2018 Nov; 43(21):4347-4351. PubMed ID: 30583639 [TBL] [Abstract][Full Text] [Related]
35. [Evaluation for druggability of traditional Chinese medicine preparations in medical institutions based on human use experience]. Zhuo JX; Qiu ZW; Zhou J; Wu YM; Yang ML; Yang ZQ Zhongguo Zhong Yao Za Zhi; 2022 Aug; 47(15):4256-4260. PubMed ID: 36046916 [TBL] [Abstract][Full Text] [Related]
36. [Quality process control system of Chinese medicine preparation based on "holistic view"]. Wang YQ; Jiao JJ; Wu ZF; Zheng Q; Yang M Zhongguo Zhong Yao Za Zhi; 2018 Jan; 43(1):197-203. PubMed ID: 29552832 [TBL] [Abstract][Full Text] [Related]
37. Private and public values of innovation: A patent analysis of synthetic biology. Ribeiro B; Shapira P Res Policy; 2020 Feb; 49(1):103875. PubMed ID: 32015589 [TBL] [Abstract][Full Text] [Related]
38. The innovation value chain of patents: Breakthrough in the patent commercialization trap in Chinese universities. Gong H; Nie L; Peng Y; Peng S; Liu Y PLoS One; 2020; 15(3):e0230805. PubMed ID: 32214371 [TBL] [Abstract][Full Text] [Related]
39. [Application of "major scientific issues and engineering technology difficulties in traditional Chinese medicine(2019-2021)" in national science and t echnology layout]. Fang ZH; Wang F; Han L; Li G; Wen CL; Han JY; You LZ; Xu Y; Gao ZY; Fang NY; Zhang XX Zhongguo Zhong Yao Za Zhi; 2023 Mar; 48(5):1137-1144. PubMed ID: 37005799 [TBL] [Abstract][Full Text] [Related]
40. Which ship-integrated power system enterprises are more competitive from the perspective of patent? Li D; Li X PLoS One; 2021; 16(5):e0252020. PubMed ID: 34029353 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]